Characterization of the Cytochrome P450 CYP716C52 in Celastrol Biosynthesis and Its Applications in Engineered Saccharomyces cerevisiae

• Published in: Journal of natural products (Washington, D.C.) D.C.), 2024-02, Vol.87 (2), p.176-185
• Main Authors: Lu, Yun, Liu, Yuan, Zhang, Yifeng, Gao, Haiyun, Chen, Xiaochao, Tu, Lichan, Luo, Yunfeng, Jiang, Zhouqian, Yin, Yan, Zhou, Jiawei, Hu, Tianyuan, Wu, Xiaoyi, Wang, Jiadian, Gao, Wei, Huang, Luqi
• Format: Article
• Language: English
• Subjects: Cytochrome P-450 Enzyme System - genetics; Cytochrome P-450 Enzyme System - metabolism; Molecular Docking Simulation; Pentacyclic Triterpenes; Saccharomyces cerevisiae - metabolism; Tripterygium - genetics; Triterpenes - metabolism
• ISSN: 0163-3864; 1520-6025
• DOI: 10.1021/acs.jnatprod.3c00674

Celastrol is a bioactive pentacyclic triterpenoid with promising therapeutic effects that is mainly distributed in Celastraceae plants. Although some enzymes involved in the celastrol biosynthesis pathway have been reported, many biosynthetic steps remain unknown. Herein, transcriptomics and metabolic profiles of multiple species in Celastraceae were integrated to screen for cytochrome P450s (CYPs) that are closely related to celastrol biosynthesis. The CYP716 enzyme, TwCYP716C52, was found to be able to oxidize the C-2 position of polpunonic acid, a precursor of celastrol, to form the wilforic acid C. RNAi-mediated repression of TwCYP716C52 in Tripterygium wilfordii suspension cells further confirmed its involvement in celastrol biosynthesis. The C-2 catalytic mechanisms of TwCYP716C52 were further explored by using molecular docking and site-directed mutagenesis experiments. Moreover, a modular optimization strategy was used to construct an engineered yeast to produce wilforic acid C at a titer of 5.8 mg·L–1. This study elucidates the celastrol biosynthetic pathway and provides important functional genes and sufficient precursors for further enzyme discovery.